How is this different from other cancer research?
The TIOB was created to fuel research efforts, not to compete with them.
Research has led to the creation of many immunotherapies, like CAR-T, to help treat different cancers. We want to improve the understanding about how immunotherapies are performing in a real-world setting.
Through Baylor Scott & White Research Institute (BSWRI), we can safely collect biospecimens from a very large, and uniquely diverse, patient population. Those samples can then be studied with the purpose of improving and increasing the types of immunotherapies available.
The data and biological samples we gather will allow researchers to dig into the microscopic nuances that can change how one patient responds to a treatment compared with another, or what small changes can be made to improve the effectiveness of a treatment option.